Redefining Device Innovation--An Interview with John Abele
Over the past 25 years, few medical device companies have played as large a role in fostering medical device innovation as Boston Scientific. Indeed, through much of the 1980s, Boston Scientific created a new model for a medical device company as technology innovator--one that made the physician less a customer than an ally in the promotion and dissemination of new technology. The visionary behind this new model for device innovation: John Abele, director, founder and chairman at Boston Scientific, who has been a guiding light behind the company's extraordinary technology story--a story that continues today, not just in Boston's dramatic success in drug-eluting stents, but also in the diverse technology portfolio the company has assembled. In the following interview, Abele, whose training was neither in medicine nor engineering, talks about his early days in the medical device industry and the principles that guided him.
You may also be interested in...
Researchers say “no strong” evidence shows high vitamin D intake is beneficial to preventing or treating COVID-19, but adequate levels are needed to support immunity. Other researchers say countries should increase recommended vitamin D levels with “very suggestive” evidence supporting its effect against COVID-19 severity.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
Not Your Grandfather’s CAPA: Case For Quality Pilot Gives Corrective And Preventive Action A Facelift
Big changes are afoot when it comes to CAPA. Ten medtech manufacturing sites are playing in a pilot program that uses a novel framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach that separates higher-risk events from others that don’t need to be elevated to the level of a traditional CAPA. Medtronic quality/regulatory expert Kathryn Merrill weighs in.